SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ambuja Cements Ltd

Industry : Cement - North India

BSE Code

ISIN Demat

Book Value()

500425

INE079A01024

204.8376183

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMBUJACEM

30.83

110450.12

EPS(TTM)

Face Value()

Div & Yield %

14.42

0.45

Back

jmc projects (india) ltd

JFL Life Sciences standalone net profit rises 172.97% in the December 2025 quarter

Jan 29,2026

Net profit of JFL Life Sciences rose 172.97% to Rs 2.02 crore in the quarter ended December 2025 as against Rs 0.74 crore during the previous quarter ended December 2024. Sales rose 26.31% to Rs 26.84 crore in the quarter ended December 2025 as against Rs 21.25 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	26.84	21.25	26
OPM %	12.48	6.35	-
PBDT	2.98	1.15	159
PBT	2.71	0.99	174
NP	2.02	0.74	173

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)